United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 83,980 | 79,730 | 75,862 | 75,032 | 68,556 |
| Cost of Goods | 10,084 | 8,986 | 8,107 | 7,741 | 7,332 |
| Gross Profit | 73,896 | 70,744 | 67,755 | 67,291 | 61,224 |
| Operating Expenses | 78,101 | 51,163 | 201,722 | 49,972 | 42,566 |
| Operating Income | -4,121 | 20,567 | -133,860 | 18,060 | 18,990 |
| Interest Expense | 3,248 | 2,637 | 2,422 | 2,624 | 3,601 |
| Other Income | 1,826 | 2,066 | 1,066 | 1,819 | 3,578 |
| Pre-tax Income | -5,543 | 19,996 | -135,216 | 17,255 | 18,967 |
| Income Tax | -3,199 | 6,799 | -52,921 | 6,285 | 6,905 |
| Net Income Continuous | -2,344 | 13,197 | -82,295 | 10,970 | 12,062 |
| Net Income | $-2,344 | $13,197 | $-82,295 | $10,970 | $12,062 |
| EPS Basic Total Ops | -0.04 | 0.25 | -1.81 | 0.24 | 0.27 |
| EPS Basic Continuous Ops | -0.04 | 0.25 | -1.81 | 0.24 | 0.27 |
| EPS Diluted Total Ops | -0.04 | 0.24 | -1.76 | 0.22 | 0.25 |
| EPS Diluted Continuous Ops | -0.04 | 0.24 | -1.75 | 0.22 | 0.25 |
| EBITDA(a) | $2,292 | $26,724 | $-128,713 | $22,767 | $23,430 |